Norgesic Tablet
Product Images NDC 61825-305

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Norgesic (NDC 61825-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Galt Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Capture1 (Capture)

This is a description for Norgesic tablets. The tablets contain orphenadrine citrate, aspirin, and caffeine and are used to manage pain. The dosage instructions are not available and the package should be kept out of the reach of children. The tablets should be stored below 30°C (86°F). There is an imprint area provided for the packaging.*

FDA Label Image

Structure (Structure1)

This is not-available as the text is incomplete and does not provide any context.*

FDA Label Image

Structure1 (Structure2)

This text is not available, as it does not contain any readable words or context.*

FDA Label Image

Structure2 (Structure3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.